ÂÜÀòÂÒÂ×

Oxular

0 followers
‌

Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.

Industries

Employees

11-50

Links


Org chart

Thomas Cavanagh
Chief Executive Officer
Collapse
Ronald Yamamoto
Chief Scientific Officer
Paul Pritchard
Associate Director of Procurement and Supply Chain
Stacey Tucker
Finance Director

Board & advisors